Does regional anaesthesia and analgesia or opioid analgesia influence recurrence after primary cancer surgery? An update of available evidence

Best Practice and Research: Clinical Anaesthesiology

Volumn 27, Issue 4, 2013, Pages 441-456

  Ash, Simon A ^a   Buggy, Donal J ^a,b,c  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

anaesthesia; cancer; metastases; NSAIDs; opioids; recurrence; regional

Indexed keywords

ACETYLSALICYLIC ACID; BUPIVACAINE; CLONIDINE; CYCLOOXYGENASE 2; ENDORPHIN; FENTANYL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOFLURANE; KETAMINE; LIDOCAINE; MORPHINE; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROPOFOL; PROSTAGLANDIN E2; REMIFENTANIL; THIOPENTAL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VOLATILE AGENT;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TRANSFUSION; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CELL INTERACTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC PAIN; CIRCULATING TUMOR CELL; COLON CANCER; COLORECTAL CANCER; DRUG CYTOTOXICITY; EPIDURAL ANESTHESIA; GENE MUTATION; GENERAL ANESTHESIA; HUMAN; HYPOTHERMIA; IMMUNOMODULATION; LARYNX CANCER; LIVER METASTASIS; LOW DRUG DOSE; MASTECTOMY; MELANOMA; META ANALYSIS (TOPIC); METASTASIS; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NONHUMAN; OVARY CANCER; OVERALL SURVIVAL; PEROPERATIVE COMPLICATION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REGIONAL ANESTHESIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL ANESTHESIA; SURGICAL INJURY; SURGICAL PATIENT; SURGICAL STRESS; TREATMENT OUTCOME; TUMOR IMMUNITY; TUMOR LOCALIZATION; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER; VASCULAR DISEASE;

ANAESTHESIA; CANCER; METASTASES; NSAIDS; OPIOIDS; RECURRENCE; REGIONAL;

ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; ANESTHESIA; ANESTHESIA, CONDUCTION; ANIMALS; CHRONIC PAIN; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; SURVIVAL RATE;

EID: 84888427899     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2013.10.005     Document Type: Review

References (186)

1. American Cancer Society Cancer facts & figures 2013 2013 American Cancer Society Atlanta
2. L. Colvin, K. Forbes, and M. Fallon Difficult pain BMJ 332 7549 2006 1081 1083
3. C.B. Harrington, J.A. Hansen, and M. Moskowitz It's not over when it's over: long-term symptoms in cancer survivors-a systematic review Int J Psychiatry Med 40 2 2010 163 181
4. S. Kurosawa Anesthesia in patients with cancer disorders Curr Opin Anaesthesiol 25 3 2012 376 384
5. O. Schmidt-Kittler, T. Ragg, and A. Daskalakis From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci U S A 100 13 2003 7737 7742
6. N. Almog, L. Ma, and R. Raychowdhury Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype Cancer Res 69 3 2009 836 844
7. J.A. Aguirre-Ghiso The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities Cell Cycle 5 16 2006 1740 1743
8. R. Demicheli, M. Terenziani, and P. Valagussa Local recurrences following mastectomy: support for the concept of tumor dormancy J Natl Cancer Inst 86 1 1994 45 48
9. P. Forget, P.G. Coulie, and M. Retsky Is there a rationale for an anesthesiologist's role against cancer recurrence? Acta Anaesthesiol Belg 64 1 2013 15 24
10. M. Retsky New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms Int J Environ Res Public Health 6 1 2009 329 348
11. P. Forget, J. Vandenhende, and M. Berliere Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis Anesth Analg 110 6 2010 1630 1635
12. R. Demicheli, E. Biganzoli, and P. Boracchi Recurrence dynamics does not depend on the recurrence site Breast Cancer Res 10 5 2008 R83
13. Arimidex, Tamoxifen Alone or in Combination (ATAC) Trialists Group J.F. Forbes, and J. Cuzick Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Lancet Oncol 9 1 2008 45 53
14. J. Varani, E.J. Lovett 3rd, and J. Lundy A model of tumor cell dormancy: effects of anesthesia and surgery J Surg Oncol 17 1 1981 9 14
15. J.E. Talmadge, and I.J. Fidler AACR centennial series: the biology of cancer metastasis: historical perspective Cancer Res 70 14 2010 5649 5669
16. G.L. Snyder, and S. Greenberg Effect of anaesthetic technique and other perioperative factors on cancer recurrence Br J Anaesth 105 2 2010 106 115
17. T. Kavanagh, and D.J. Buggy Can anaesthetic technique effect postoperative outcome? Curr Opin Anaesthesiol 25 2 2012 185 198
18. L.A. Colvin, M.T. Fallon, and D.J. Buggy Cancer biology, analgesics, and anaesthetics: is there a link? Br J Anaesth 109 2 2012 140 143
19. A. Heaney, and D.J. Buggy Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth 109 Suppl. 1 2012 i17 i28
20. H. Niwa, D.J. Rowbotham, D.G. Lambert, and D.J. Buggy Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery? J Anesth 27 5 2013 731 741 10.1007/s00540-013-1615-7 [in print]
21. L. Mao, S. Lin, and J. Lin The effects of anesthetics on tumor progression Int J Physiol Pathophysiol Pharmacol 5 1 2013 1 10
22. I.J. Fidler The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat Rev Cancer 3 6 2003 453 458
23. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
24. R.R. Langley, and I.J. Fidler The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs Int J Cancer 128 11 2011 2527 2535
25. S.C. O'Riain, D.J. Buggy, and M.J. Kerin Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2 Anesth Analg 100 1 2005 244 249
26. S. Demaria, E. Pikarsky, and M. Karin Cancer and inflammation: promise for biologic therapy J Immunother 33 4 2010 335 351
27. M. Hussain, A. Javeed, and M. Ashraf Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy Pharmacol Res 66 1 2012 7 18
28. S. Kurosawa, G. Matsuzaki, and M. Harada Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development Eur J Immunol 23 5 1993 1029 1033
29. I. Conrick-Martin, M.R. Kell, and D.J. Buggy Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function J Clin Anesth 24 1 2012 3 7
30. S. Ben-Eliyahu, G.G. Page, and R. Yirmiya Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity Int J Cancer 80 6 1999 880 888
31. A. Gottschalk, S. Sharma, and J. Ford Review article: the role of the perioperative period in recurrence after cancer surgery Anesth Analg 110 6 2010 1636 1643
32. P. Forget, V. Collet, and P. Lavand'homme Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages Eur J Anaesthesiol 27 3 2010 233 240
33. P. Forget, and M. De Kock Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity Ann Fr Anesth Reanim 28 9 2009 751 768
34. G. Shakhar, and S. Ben-Eliyahu Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 10 8 2003 972 992
35. F. Pages, A. Berger, and M. Camus Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 353 25 2005 2654 2666
36. B. Qian, Y. Deng, and J.H. Im A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth PLoS One 4 8 2009 e6562
37. E. Di Carlo, G. Forni, and P. Musiani Neutrophils in the antitumoral immune response Chem Immunol Allergy 83 2003 182 203
38. T. Karnezis, R. Shayan, and C. Caesar VEGF-D promotes tumour metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium Cancer Cell 21 2 2012 181 195
39. S. Ostrand-Rosenberg, and P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J Immunol 182 8 2009 4499 4506
40. C.A. Dinarello The paradox of pro-inflammatory cytokines in cancer Cancer Metastasis Rev 25 3 2006 307 313
41. D. Raman, P.J. Baugher, and Y.M. Thu Role of chemokines in tumor growth Cancer Lett 256 2 2007 137 165
42. J.P. Waymack, E. Flescher, and J. Venkatraman Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor J Surg Oncol 48 4 1991 239 245
43. K. Okuno, H. Jinnai, and Y.S. Lee A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases Surg Today 25 11 1995 954 958
44. R. Demicheli, M.W. Retsky, and W.J. Hrushesky Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures Nat Clin Pract Oncol 4 12 2007 699 710
45. R. Demicheli, M.W. Retsky, and W.J. Hrushesky The effects of surgery on tumor growth: a century of investigations Ann Oncol 19 11 2008 1821 1828
46. Y. Goldfarb, L. Sorski, and M. Benish Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses Ann Surg 253 4 2011 798 810
47. S. Motohashi, and T. Nakayama Natural killer T cell-mediated immunotherapy for malignant diseases Front Biosci 1 2009 108 116
48. B. Afsharimani, P. Cabot, and M.O. Parat Morphine and tumor growth and metastasis Cancer Metastasis Rev 30 2 2011 225 238
49. Y. Kawaraguchi, Y.T. Horikawa, and A.N. Murphy Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins Anesthesiology 115 3 2011 499 508
50. S. Panagiotou, E. Bakogeorgou, and E. Papakonstanti Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: involvement of cytoskeletal elements J Cell Biochem 73 2 1999 204 211
51. P. Ecimovic, D. Murray, and P. Doran Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene Br J Anaesth 107 6 2011 916 923
52. C.A. Deegan, D. Murray, and P. Doran Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro Br J Anaesth 103 5 2009 685 690
53. C.A. Deegan, D. Murray, and P. Doran Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery Reg Anesth Pain Med 35 6 2010 490 495
54. M. Baum, R. Demicheli, and W. Hrushesky Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41 4 2005 508 515
55. P.A. Singleton, and J. Moss Effect of perioperative opioids on cancer recurrence: a hypothesis Future Oncol 6 8 2010 1237 1242
56. E. Neeman, and S. Ben-Eliyahu Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement Brain Behav Immun 30 Suppl. 2013 S32 S40
57. M. Benish, I. Bartal, and Y. Goldfarb Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis Ann Surg Oncol 15 7 2008 2042 2052
58. H. Wada, S. Seki, and T. Takahashi Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance Anesthesiology 106 3 2007 499 506
59. C.F. Peeters, R.M. de Waal, and T. Wobbes Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation Int J Cancer 119 6 2006 1249 1253
60. G. Peach, C. Kim, and E. Zacharakis Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review Br J Cancer 102 9 2010 1327 1334
61. J.M. Lloyd, C.M. McIver, and S.A. Stephenson Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells Clin Cancer Res 12 2 2006 417 423
62. H. Iinuma, T. Watanabe, and K. Mimori Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer J Clin Oncol 29 12 2011 1547 1555
63. T.J. Molloy, A.J. Bosma, and L.O. Baumbusch The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients Breast Cancer Res 13 3 2011 R61
64. F.C. Bidard, A. Vincent-Salomon, and S. Gomme Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse Clin Cancer Res 14 11 2008 3306 3311
65. Y. Park, T. Kitahara, and T. Urita Expected clinical applications of circulating tumor cells in breast cancer World J Clin Oncol 2 8 2011 303 310
66. D.J. Buggy, and G. Smith Epidural anaesthesia and analgesia: better outcome after major surgery?. Growing evidence suggests so BMJ 319 7209 1999 530 531
67. Y. Goldfarb, and S. Ben-Eliyahu Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches Breast Dis 26 2006 99 114
68. A.E. Bogden, J.P. Moreau, and P.A. Eden Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition Br J Cancer 75 7 1997 1021 1027
69. S.O. Hofer, D. Shrayer, and J.S. Reichner Wound-induced tumor progression: a probable role in recurrence after tumor resection Arch Surg 133 4 1998 383 389
70. H.L. Wang, T. Ning, and M. Li Effect of endostatin on preventing postoperative progression of distant metastasis in a murine lung cancer model Tumori 97 6 2011 787 793
71. M. Looney, P. Doran, and D.J. Buggy Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer Anesthesiology 113 5 2010 1118 1125
72. J.W. Lee, M.M. Shahzad, and Y.G. Lin Surgical stress promotes tumor growth in ovarian carcinoma Clin Cancer Res 15 8 2009 2695 2702
73. P.H. Thaker, L.Y. Han, and A.A. Kamat Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Nat Med 12 8 2006 939 944
74. P.S. Myles, P. Peyton, and B. Silbert Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial BMJ 342 2011 d1491
75. H.G. Bjorneklett, C. Lindemalm, and A. Rosenblad A randomised controlled trial of support group intervention after breast cancer treatment: results on anxiety and depression Acta Oncol 51 2 2012 198 207
76. T.I. Barron, R.M. Connolly, and L. Sharp Beta blockers and breast cancer mortality: a population- based study J Clin Oncol 29 19 2011 2635 2644
77. R.S. Weber, N. Jabbour, and R.C. Martin 2nd Anemia and transfusions in patients undergoing surgery for cancer Ann Surg Oncol 15 1 2008 34 45
78. T. Ng, B.A. Ryder, and H. Chern Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer J Thorac Cardiovasc Surg 143 4 2012 815 819
79. A.M. Churchhouse, T.J. Mathews, and O.M. McBride Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer? Interact Cardiovasc Thorac Surg 14 1 2012 85 90
80. S. Atzil, M. Arad, and A. Glasner Blood transfusion promotes cancer progression: a critical role for aged erythrocytes Anesthesiology 109 6 2008 989 997
81. M. Moslemi-Kebria, S.A. El-Nashar, and G.D. Aletti Intraoperative hypothermia during cytoreductive surgery for ovarian cancer and perioperative morbidity Obstet Gynecol 119 3 2012 590 596
82. G.G. Page, W.P. Blakely, and S. Ben-Eliyahu Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats Pain 90 1-2 2001 191 199
83. G.G. Page, J.S. McDonald, and S. Ben-Eliyahu Pre-operative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery Br J Anaesth 81 2 1998 216 223
84. S. Bar-Yosef, R. Melamed, and G.G. Page Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats Anesthesiology 94 6 2001 1066 1073
85. B. Beilin, Y. Shavit, and J. Hart Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period Anesth Analg 82 3 1996 492 497
86. M. Liljefors, B. Nilsson, and A.L. Hjelm Skog Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A Int J Cancer 105 5 2003 717 723
87. A.K. Exadaktylos, D.J. Buggy, and D.C. Moriarty Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105 4 2006 660 664
88. B. Biki, E. Mascha, and D.C. Moriarty Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis Anesthesiology 109 2 2008 180 187
89. B.C. Tsui, S. Rashiq, and D. Schopflocher Epidural anesthesia and cancer recurrence rates after radical prostatectomy Can J Anaesth 57 2 2010 107 112
90. R. Christopherson, K.E. James, and M. Tableman Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia Anesth Analg 107 1 2008 325 332
91. A. Gottschalk, J.G. Ford, and C.C. Regelin Association between epidural analgesia and cancer recurrence after colorectal cancer surgery Anesthesiology 113 1 2010 27 34
92. P.Y. Wuethrich, S.F. Hsu Schmitz, and T.M. Kessler Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study Anesthesiology 113 3 2010 570 576
93. P. Forget, B. Tombal, and J.L. Scholtes Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28 12 2011 830 835
94. R. Melamed, S. Bar-Yosef, and G. Shakhar Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures Anesth Analg 97 5 2003 1331 1339
95. K. Yuki, N.S. Astrof, and C. Bracken Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1 Anesthesiology 113 3 2010 600 609
96. T. Loop, D. Dovi-Akue, and M. Frick Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro Anesthesiology 102 6 2005 1147 1157
97. H. Wei, G. Liang, and H. Yang The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors Anesthesiology 108 2 2008 251 260
98. J.M. Huitink, M. Heimerikxs, and M. Nieuwland Volatile anesthetics modulate gene expression in breast and brain tumor cells Anesth Analg 111 6 2010 1411 1415
99. A.N. Tavare, N.J. Perry, and L.L. Benzonana Cancer recurrence after surgery: direct and indirect effects of anesthetic agents Int J Cancer 130 6 2012 1237 1250
100. B. Muller-Edenborn, B. Roth-Z'graggen, and K. Bartnicka Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9 Anesthesiology 117 2 2012 293 301
101. E. Fleischmann, C. Marschalek, and K. Schlemitz Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial BMC Anesthesiol 9 2009 1
102. N. Ohta, Y. Ohashi, and Y. Fujino Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response Anesth Analg 109 3 2009 793 800
103. B. Beilin, Y. Rusabrov, and Y. Shapira Low-dose ketamine affects immune responses in humans during the early postoperative period Br J Anaesth 99 4 2007 522 527
104. T. Inada, K. Kubo, and K. Shingu Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol J Anesth 25 4 2011 569 575
105. M. Sakaguchi, Y. Kuroda, and M. Hirose The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor Anesth Analg 102 4 2006 1103 1107
106. P. Lirk, R. Berger, and M.W. Hollmann Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro Br J Anaesth 109 2 2012 200 207
107. E. Lucchinetti, A.E. Awad, and M. Rahman Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing Anesthesiology 116 4 2012 841 856
108. R. Werdehausen, S. Braun, and S. Fazeli Lipophilicity but not stereospecificity is a major determinant of local anaesthetic-induced cytotoxicity in human T-lymphoma cells Eur J Anaesthesiol 29 1 2012 35 41
109. I.A. Luthy, A. Bruzzone, and C.P. Pinero Adrenoceptors: non conventional target for breast cancer? Curr Med Chem 16 15 2009 1850 1862
110. H. Sobel, and G. Bonorris Effect of morphine on rats bearing Walker carcinosarcoma 256 Nature 196 1962 896 897
111. B. Afsharimani, P.J. Cabot, and M.O. Parat Morphine use in cancer surgery Front Pharmacol 2 2011 46
112. S. Franchi, S. Moretti, and M. Castelli Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages Brain Behav Immun 26 3 2012 480 488
113. I. Tegeder, S. Grosch, and A. Schmidtko G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation Cancer Res 63 8 2003 1846 1852
114. M. Lazarczyk, E. Matyja, and A.W. Lipkowski A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro Peptides 31 8 2010 1606 1612
115. K. Gach, J. Szemraj, and A. Wyrebska The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line Mol Biol Rep 38 2 2011 1231 1236
116. K. Gach, A. Wyrebska, and J. Fichna The role of morphine in regulation of cancer cell growth Naunyn Schmiedebergs Arch Pharmacol 384 3 2011 221 230
117. X. Lin, Y.J. Wang, and Q. Li Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway FEBS J 276 7 2009 2022 2036
118. L. Koodie, S. Ramakrishnan, and S. Roy Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway Am J Pathol 177 2 2010 984 997
119. D.K. Sarkar, S. Murugan, and C. Zhang Regulation of cancer progression by beta-endorphin neuron Cancer Res 72 4 2012 836 840
120. J. Kraus Regulation of mu-opioid receptors by cytokines Front Biosci 1 2009 164 170
121. F.E. Lennon, T. Mirzapoiazova, and B. Mambetsariev Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis Anesthesiology 116 4 2012 857 867
122. F.E. Lennon, J. Moss, and P.A. Singleton The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology 116 4 2012 940 945
123. B. Mathew, F.E. Lennon, and J. Siegler The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation Anesth Analg 112 3 2011 558 567
124. P.A. Singleton, J.G. Garcia, and J. Moss Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis Mol Cancer Ther 7 6 2008 1669 1679
125. M. Hayashida, M. Nagashima, and Y. Satoh Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype Pharmacogenomics 9 11 2008 1605 1616
126. S. Kasai, M. Hayashida, and I. Sora Candidate gene polymorphisms predicting individual sensitivity to opioids Naunyn Schmiedebergs Arch Pharmacol 377 4-6 2008 269 281
127. A.V. Bortsov, R.C. Millikan, and I. Belfer mu-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer Anesthesiology 116 4 2012 896 902
128. P.A. Singleton, M.W. Lingen, and M.J. Fekete Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation Microvasc Res 72 1-2 2006 3 11
129. M. Farooqui, Y. Li, and T. Rogers COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia Br J Cancer 97 11 2007 1523 1531
130. N. Fujioka, J. Nguyen, and C. Chen Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer Anesth Analg 113 6 2011 1353 1364
131. K. Gach, J. Szemraj, and J. Fichna The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line Chem Biol Drug Des 74 4 2009 390 396
132. G. Nylund, A. Pettersson, and C. Bengtsson Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon Dig Dis Sci 53 2 2008 461 466
133. P.H. Norman, P.F. Thall, and R.V. Purugganan A possible association between aprotinin and improved survival after surgery for mesothelioma Cancer 115 4 2009 833 841
134. Y. Harimaya, K. Koizumi, and T. Andoh Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells Cancer Lett 187 1-2 2002 121 127
135. P.N. Hsiao, M.C. Chang, and W.F. Cheng Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways Toxicology 256 1-2 2009 83 91
136. I. Hatsukari, N. Hitosugi, and R. Ohno Induction of apoptosis by morphine in human tumor cell lines in vitro Anticancer Res 27 2 2007 857 864
137. B. Singh, J.A. Berry, and A. Shoher COX-2 involvement in breast cancer metastasis to bone Oncogene 26 26 2007 3789 3796
138. B. Singh, J.A. Berry, and A. Shoher COX-2 induces IL-11 production in human breast cancer cells J Surg Res 131 2 2006 267 275
139. B. Singh, J.A. Berry, and L.E. Vincent Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer J Surg Res 134 1 2006 44 51
140. A. Lucci, S. Krishnamurthy, and B. Singh Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow Breast Cancer Res Treat 117 1 2009 61 68
141. B. Singh, K.R. Cook, and L. Vincent Role of COX-2 in tumorospheres derived from a breast cancer cell line J Surg Res 168 1 2011 e39 e49
142. B. Singh, L. Vincent, and J.A. Berry Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells J Surg Res 140 2 2007 220 226
143. B. Singh, K.R. Cook, and L. Vincent Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells J Surg Res 147 2 2008 240 246
144. B. Singh, L.R. Irving, and K. Tai Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines J Surg Res 163 2 2010 235 243
145. M. Tsujii Cyclooxygenase, cancer stem cells and DNA methylation play important roles in colorectal carcinogenesis Digestion 87 1 2013 12 16
146. Y.C. Guo, C.M. Chang, and W.L. Hsu Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization Molecules 18 6 2013 6584 6596
147. L. Brand, J. Munding, and C.P. Pox ss-catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy Int J Colorectal Dis 28 8 2013 1091 1098
148. J.Y. Lee, S.K. Myung, and Y.S. Song Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies Gynecol Oncol 129 3 2013 613 619
149. Y.F. Chen, R.Z. Luo, and Y. Li High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma Eur Arch Otorhinolaryngol 270 3 2013 1009 1017
150. H.L. Ke, H.P. Tu, and H.H. Lin Cyclooxygenase-2 (COX-2) up-regulation is a prognostic marker for poor clinical outcome of upper tract urothelial cancer Anticancer Res 32 9 2012 4111 4116
151. S. Kraus, I. Naumov, and N. Arber COX-2 active agents in the chemoprevention of colorectal cancer Recent Results Cancer Res 191 2013 95 103
152. J. Al-Maghrabi, A. Buhmeida, and E. Emam Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma World J Gastroenterol 18 15 2012 1793 1799
153. C. McCowan, A.J. Munro, and P.T. Donnan Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality Eur J Cancer 49 5 2013 1049 1057
154. K.S. Choe, J.E. Cowan, and J.M. Chan Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy J Clin Oncol 30 28 2012 3540 3544
155. N.G. Zaorsky, M.K. Buyyounouski, and T. Li Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy Int J Radiat Oncol Biol Phys 84 1 2012 e13 e17
156. R. Benamouzig, B. Uzzan, and J. Deyra Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial Gut 61 2 2012 255 261
157. P.M. Rothwell, J.F. Price, and F.G. Fowkes Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Lancet 379 9826 2012 1602 1612
158. E.J. Jacobs, C.C. Newton, and S.M. Gapstur Daily aspirin use and cancer mortality in a large US cohort J Natl Cancer Inst 104 16 2012 1208 1217
159. B. Singh, and A. Lucci Role of cyclooxygenase-2 in breast cancer J Surg Res 108 1 2002 173 179
160. M.D. Holmes, W.Y. Chen, and L. Li Aspirin intake and survival after breast cancer J Clin Oncol 28 9 2010 1467 1472
161. J. Burn, A.M. Gerdes, and F. Macrae Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Lancet 378 9809 2011 2081 2087
162. D. Wang, and R.N. Dubois The role of COX-2 in intestinal inflammation and colorectal cancer Oncogene 29 6 2010 781 788
163. M.J. Thun, E.J. Jacobs, and C. Patrono The role of aspirin in cancer prevention Nat Rev Clin Oncol 9 5 2012 259 267
164. A. Ferrandez, E. Piazuelo, and A. Castells Aspirin and the prevention of colorectal cancer Best Pract Res Clin Gastroenterol 26 2 2012 185 195
165. A.G. Lopes Jr., C.J. Rodrigues, and L.H. Lopes Differences in tumour growth, tumour cell proliferation and immune function after laparoscopy and laparotomy in an animal model HPB 3 3 2001 213 217
166. D.I. Sessler Does regional analgesia reduce the risk of cancer recurrence? A hypothesis Eur J Cancer Prev 17 3 2008 269 272
167. N.M. Moselli, E. Baricocchi, and D. Ribero Intraoperative epidural analgesia prevents the early proinflammatory response to surgical trauma. Results from a prospective randomized clinical trial of intraoperative epidural versus general analgesia Ann Surg Oncol 18 10 2011 2722 2731
168. M.P. Yeager, and K.M. Rosenkranz Cancer recurrence after surgery: a role for regional anesthesia? Reg Anesth Pain Med 35 6 2010 483 484
169. H. Ismail, K.M. Ho, and K. Narayan Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study Br J Anaesth 105 2 2010 145 149
170. A. Gupta, A. Bjornsson, and M. Fredriksson Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden Br J Anaesth 107 2 2011 164 170
171. L. Lin, C. Liu, and H. Tan Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis Br J Anaesth 106 6 2011 814 822
172. G.S. de Oliveira Jr., S. Ahmad, and J.C. Schink Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery Reg Anesth Pain Med 36 3 2011 271 277
173. R. Lai, Z. Peng, and D. Chen The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma Anesth Analg 114 2 2012 290 296
174. A. Day, R. Smith, and I. Jourdan Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer Br J Anaesth 109 2 2012 185 190
175. A. Gottschalk, G. Brodner, and H.K. Van Aken Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth 109 2 2012 253 259
176. K.C. Cummings 3rd, F. Xu, and L.C. Cummings A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study Anesthesiology 116 4 2012 797 806
177. H.J. Lacassie, J. Cartagena, and J. Branes The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the chilean population Anesth Analg 117 3 2013 653 660
178. F. Merquiol, A.S. Montelimard, and A. Nourissat Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: a retrospective propensity-matched analysis Reg Anesth Pain Med 38 5 2013 398 402
179. P.Y. Wuethrich, G.N. Thalmann, and U.E. Studer Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer PLoS One 8 8 2013 e72873
180. M. Binczak, E. Tournay, and V. Billard Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival? Ann Fr Anesth Reanim 32 5 2013 e81 e88
181. W.K. Chen, and C.H. Miao The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies PLoS One 8 2 2013 e56540
182. T.J. Smith, P.S. Staats, and T. Deer Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival J Clin Oncol 20 19 2002 4040 4049
183. K.K. Varadhan, K.R. Neal, and C.H. Dejong The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials Clin Nutr 29 4 2010 434 440
184. P. Forget, D. Leonard, and A. Kartheuser Endpoint selection and unreported analgesic use may render oncologic studies inconclusive Anesthesiology 114 3 2011 717 author reply 718
185. M.J. Proctor, D.S. Morrison, and D. Talwar A comparison of inflammation-based prognostic scores in patients with cancer. A glasgow inflammation outcome study Eur J Cancer 47 17 2011 2633 2641
186. G.J. Macfarlane, J. McBeth, and A.J. Silman Widespread body pain and mortality: prospective population based study BMJ 323 7314 2001 662 665